42 U.S.C. § 300cc–11 — Clinical evaluation units at National Institutes of Health

(a) In general: The Secretary, working through the Directors of the National Cancer Institute and the National Institute of Allergy and Infectious Diseases, must set up a clinical evaluation unit for each of those two Institutes at the Clinical Center of the National Institutes of Health. Each unit must (1) test experimental AIDS treatments that came out of the preclinical drug development program — including testing ways to diagnose immune deficiency and to predict, diagnose, prevent, and treat opportunistic cancers and infections — and may (2) also test experimental AIDS treatments developed by any other NIH research institute or by any other organization. (b) Personnel and administrative support: (1) For the work described in (a), the Secretary, through the Director of NIH, must give each unit either (A)(i) at least 50 beds, or (ii) outpatient capacity for AIDS care at least twice what the Clinical Center had on June 1, 1988, and (B) enough staff, administrative support, and other support services. (2) All of this must be added on top of the facilities, staff, and support the Clinical Center already had for treating other diseases — it cannot come from redirecting existing resources. (c) Authorization of appropriations: Congress could appropriate whatever money was needed to carry out this section.